Nasdaq atai.

Mar 31, 2023 · In its 2022 Q4 report, Atai reiterated that it is well capitalized, with a cash runway into the first half of 2026. ... NASDAQ: ATAI Atai Life Sciences. Market Cap. $173M. Today's Change (-7.14% ... Other companies interested in the use of traditional, naturally derived ibogaine for substance abuse include DemeRx, a subsidiary of Peter Thiel-backed Atai Life Sciences (NASDAQ:ATAI), and ...111.91%. Get the latest ATAI Life Sciences NV (ATAI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment... Jul 14, 2021 · Some of the companies already making a big splash in the as yet small sector include COMPASS Pathways plc (NASDAQ: CMPS), Atai Life Sciences N.V. (NASDAQ: ATAI), and Seelos Therapeutics, Inc ... Nov 14, 2023 · Clinical-stage psychedelics company atai Life Sciences (NASDAQ:ATAI) reported its financial results and corporate updates for the third quarter ended September 30, 2023. In numbers: Cash, cash ...

Find the latest Earnings Report Date for ATAI Life Sciences N.V. Common Shares (ATAI) at Nasdaq.com.

Find the latest Earnings Report Date for ATAI Life Sciences N.V. Common Shares (ATAI) at Nasdaq.com.

(Part four of a four-part series) See previous stories in this series: Insider's Peek At Mammoth Of Psychedelics VCs, Palo S...NEW YORK, Dec. 13, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health ...Investing.com - ATAI Life Sciences BV (NASDAQ: ATAI) obtuvo en el tercer trimestre del año un BPA de 0.25$, 0.45$ mejor que lo esperado, pues se preveía un BPA de -0.20$.Los ingresos del trimestre se situaron en 87K$, frente a una previsión de 0$. Las acciones de ATAI Life Sciences BV cerraron en 1.15$, lo que representa una cayó un …Atai Life Sciences N.V. (NASDAQ:ATAI)’s largest hedge fund investor is Israel Englander’s Millennium Management which owns 117,716 shares that are worth $205,000. 11.Shares in Peter Thiel-backed psychedelic start-up Atai Life Sciences jumped Friday on their first day of trading on Wall Street. The newly listed Nasdaq stock opened up 40% before pulling back some.

(Part four of a four-part series) See previous stories in this series: Insider's Peek At Mammoth Of Psychedelics VCs, Palo S...

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX. Copyright © 2007-2023 FINVIZ.com. All Rights Reserved. Quantcast. × ...

Nov 29, 2023 · 4 brokers have issued 1-year price targets for Atai Life Sciences' stock. Their ATAI share price targets range from $9.00 to $20.00. On average, they expect the company's stock price to reach $12.80 in the next twelve months. This suggests a possible upside of 1,063.6% from the stock's current price. NEW YORK, Nov. 29, 2021-- atai Life Sciences, a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that it has increased its ...Nov 15, 2021 · The atai Impact program will be initially funded by 1% of the gross proceeds from our June 2021 IPO and founders’ and shareholders’ contributions. Third Quarter 2021 Financial Results. Cash ... Nov 14, 2023 · The Company’s $209M cash position and committed term loan funding is expected to fund operations into 1H 2026. NEW YORK and BERLIN, Nov. 14, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ ... In addition to the previously announced presence of comedians Eric Andre and Reggie Watts, featured speakers include atai Life Sciences’ (NASDAQ:ATAI) founder and chairman Christian Angermayer; ...

Nov 14, 2023 · The Company’s $209M cash position and committed term loan funding is expected to fund operations into 1H 2026. NEW YORK and BERLIN, Nov. 14, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ ... 8. Atai Life Sciences N.V. (NASDAQ:ATAI) Number of Hedge Fund Holders: 10 Cathie Wood’s hedge fund dumped a whopping 5.6 million shares of Germany-based Atai Life Sciences N.V. (NASDAQ:ATAI) in ...A look at the shareholders of Atai Life Sciences N.V. (NASDAQ:ATAI) can tell us which group is most powerful.And the group that holds the biggest piece of the pie …Nov 10, 2022 · atai ended the third quarter of 2022 with a cash position of $304.1 million, which combined with committed funding from the Hercules loan facility, is anticipated to provide cash runway into 2025 ... Alcohol use disorder. Treatment-resistant depression. Opiate withdrawal syndrome. PTSD. Social anxiety in autistic adults. Anxiety with a life-threatening illness. Generalized anxiety disorder ...Atai Life Sciences N.V. (NASDAQ: ATAI) took a significant step to bolster its partnership with IntelGenx Technologies Corp. . The medical technology firm, Atai, now owns a substantial 63% stake in ...ATA (Nasdaq: ATAI) is the largest professional services provider for testing, assessment and related services in China, as well as the most effective AI-enhanced Remote Invigilation products and ...

To date, the VC focus on psychedelics hasn’t proven much of a return on investment. FDA approval of drugs like psilocybin and MDMA is likely years away. The stock price of psychedelic therapy companies has tanked in recent years. In March 2023, Atai Life Sciences noted that it had laid off roughly 30% of its employees.The average trading volume of ATAI on November 29, 2023 was 536.92K shares. ATAI) stock’s latest price update. The stock price of ATAI Life Sciences N.V. (NASDAQ: ATAI) has plunged by -3.51 when compared to previous closing price of 1.14, but the company has seen a 2.80% gain in its stock price over the last five trading sessions.

NEW YORK and BERLIN, Sept. 06, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental ...Atai Life Cuts Expenses, Extends Cash Runway. Atai Life Sciences (NASDAQ: ATAI) announced fiscal second-quarter results today for the quarter ending June 30, 2022 with no revenue, but an update on expenses and cash levels. Read more here. Rubicon Organics Sales Rise as Premium Brand Grows.Quotes Summary Real-Time After-Hours Pre-Market Charts NEWS & ANALYSIS News Press Releases Analyst Research ATAI ATAI REAL TIME ATAI Real-Time Quotes 1D …Last week, I reported for Psychedelic Spotlight that famed investor Cathie Woods was dipping her toes into the world of psychedelic stocks. On February 8th, ARK’s Genomic Revolution ETF (BATS: ARKG) made an initial investment into the best financed psychedelic medicines company, atai Life Sciences (Nasdaq: ATAI).. I said at the time …Atai Life Sciences (Nasdaq: ATAI) Always at the top of the list of psychedelics companies on the move, Atai Life Sciences launched a Phase 1 study of an MDMA derivative focusing on post-traumatic stress disorder in September.ATAI Life Sciences (NASDAQ: ATAI) is another clinical-stage biotech looking to make a mark in the mental health space. Its stock took a dive recently following failed results of its Phase 2a study ...

NEW YORK and BERLIN, Sept. 27, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), which is developing EMP-01, a 3,4-methylenedioxy-methamphetamine (MDMA) derivative for ...

ATAI Life Sciences N.V. Common Shares (ATAI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Ticker Symbol: ATAI: Exchange: NASDAQ: Fiscal Year: January - December: Reporting Currency: USD: IPO Price: $15.00: CIK Code: 0001840904: CUSIP Number: N0731H103 ...DemeRx, a subsidiary of Atai Life Sciences (NASDAQ: ATAI), is developing psychedelic ibogaine for the treatment of opioid use disorder and just announced it has begun a phase 1/2a clinical trial on healthy volunteers and recreational drug users. Ibogaine is a dissociative psychoactive compound naturally found in the iboga tree, which is a …Oct 31, 2023 · Atai Life Sciences N.V. (NASDAQ:ATAI) Number of Hedge Fund Investors In Q2 2023: 7 Atai Life Sciences N.V. (NASDAQ:ATAI) is a biotechnology company developing treatments for mental health disorders. atai Life Sciences atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded in 2018 as a response to the significant unmet ...Jul 14, 2021 · Some of the companies already making a big splash in the as yet small sector include COMPASS Pathways plc (NASDAQ: CMPS), Atai Life Sciences N.V. (NASDAQ: ATAI), and Seelos Therapeutics, Inc ... ATAI Life Sciences N.V. Common Shares ... Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day. Alkermes plc (NASDAQ: ALKS) recently announced plans to present data related to nemvaleukin alfa (nemvaleukin), the company’s novel, investigational, engineered interleukin-2 (IL-2) variant immunotherapy, at the Society of Gynecologic Oncology (SGO) 2022 Annual Meeting on Women’s Cancer, taking place March 18-21, 2022.Shares in Peter Thiel-backed psychedelic start-up Atai Life Sciences jumped Friday on their first day of trading on Wall Street. The newly listed Nasdaq stock opened up 40% before pulling back some.ATAI Life Sciences N.V. Common Shares (ATAI) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.NASDAQ: ATAI LIFE SCIENCES N.V. Instrumentos de la emisora ATAI LIFE SCIENCES N.V. Tipo Valor Serie Isin Estatus Descripción; 1A: N: NL0015000DX5: ACTIVA: ACCIONES SISTEMA INTERNACIONAL DE COTIZACIONES: Estados Financieros. Puede adquirir los reportes financieros trimestrales completos de esta emisora en nuestras .The clinical-stage biopharmaceutical company atai Life Sciences N.V. (NASDAQ: ATAI), which aims to revolutionize the treatment of mental health disorders, ...

RedHill Biopharma Ltd. (NASDAQ:RDHL) said Medi-Cal - California's Medicaid Health Care program covering two million patients - has added its Talicia to its contract drug list for H. pylori ...ATAI Life Sciences (NASDAQ: ATAI) is another clinical-stage biotech looking to make a mark in the mental health space. Its stock took a dive recently following failed results of its Phase 2a study ...The new research reports from Fundamental Markets, available for free download at the links above, examine Whiting Petroleum Corporation (NYSE:WLL), ATA Inc. (NASDAQ:ATAI), Ubiquiti Networks, Inc ...Instagram:https://instagram. best stock broker appbyd co stock1964 coins valuelucid delivery numbers Find the latest analyst research for ATAI Life Sciences N.V. Common Shares (ATAI) at Nasdaq.com.The Company’s $250M cash position and committed term loan funding is expected to fund operations into 1H 2026. NEW YORK and BERLIN, May 11, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ ... bwx stockforex trading algorithm Based on 2 Wall Street analysts offering 12 month price targets for ATAI Life Sciences in the last 3 months. The average price target is $20.00 with a high ...-5.91%. Nasdaq Biotechnology Ishares ETF. VHT, 0%, -1.78%. Healthcare ETF ... atai Life Sciences B.V. is based in BERLIN. See More. ATAI Related stocks. Symbol ... pre market gappers First, MindMed (Nasdaq: MNMD, NEO: MMED) will present data from their Phase 2a clinical trial attempting to treat Generalized Anxiety Disorder using a large dose of LSD paired with therapy.. For serious MindMed investors, this will be a big moment. While in the short to medium-term stocks can fluctuate wildly, especially speculative biotech …